Tag Archives: biologics

Biologics by McKesson Selected to Provide TRUSELTIQ and LUMAKRAS

Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients

Biologics by McKesson Expands Oncology Practices Offerings

Biologics has contracted with more than 500 payers and offers more than 150 therapies

AVEO Oncology’s Limited Specialty Pharmacy Distribution Network for Fotivda Selected

Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs

BluePrint’s AYVAKIT and GAVRETO™ Selected Biologics and PantherRx Rare as Limited Specialty Pharmacies

Blueprint creates medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease

Genentech (Roche) and Blueprint Medicines Collaborate to Increase Market Access

Both Gavreto and AYVAKIT are available through Blueprint’s specialty distribution network and two specialty pharmacies: Biologics by McKesson and PantherRx

Biologics by McKesson and AllianceRx Expand Specialty Pharmacy Oncology Offerings

INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies

Biologics by McKesson Expands Specialty Pharmacy Oncology Offerings

Biologics, as part of a recent reorganization, is now joining McKesson’s Provider Solutions business within the Pharmaceutical Solutions and Services (PSaS) business unit

Immunomedics Chooses Biologics as Sole Specialty Pharmacy Distributor

Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease